Work

Effects of abiraterone acetate plus prednisone/prednisolone in high and low risk metastatic hormone sensitive prostate cancer

Year: 2018

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdy424.033

Authors: A.P. Hoyle, S.A. Ali, N.D. James, C.C. Parker, A.D. Cook, G. Attard, S. Chowdhury, W. Cross, D.P. Dearnaley, J.S. de Bono, C.E. Gilson, S. Gillessen, R. Jones, D. Matheson, M.D. Mason, A. Ritchie, M. Russell, M.K. Parmar, M.R. Sydes, N.W. Clarke

Institutions: The Christie Hospital, The Christie NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, MRC Clinical Trials Unit at UCL, University College London, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, University of Bern, Kantonsspital St. Gallen, University of Manchester, University of Glasgow, Velindre Cancer Centre, Raigmore Hospital

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2898446483

FWCI: 4.38

Cites:

Cited by: 24

Related to: 10